Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;55(1):15.
doi: 10.3892/ijmm.2024.5456. Epub 2024 Nov 8.

Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review)

Affiliations
Review

Interplay between lncRNAs and the PI3K/AKT signaling pathway in the progression of digestive system neoplasms (Review)

Xiaoyu Zhang et al. Int J Mol Med. 2025 Jan.

Abstract

Long non‑coding RNA (lncRNA) is a class of non‑coding RNA molecules located in the cytoplasm or nucleus, which can regulate chromosome structure and function by interacting with DNA, RNA, proteins and other molecules; binding to mRNA bases in a complementary manner, affecting the splicing, stabilization, translation and degradation of mRNA; acting as competing endogenous RNA competitively binds to microRNAs to regulate gene expression and participate in the regulation of various vital activities of the body. The PI3K/AKT signalling pathway plays a key role in numerous biological and cellular processes, such as cell proliferation, invasion, migration and angiogenesis. It has been found that the lncRNA/PI3K/AKT axis regulates the expression of cancer‑related genes and thus tumour progression. The abnormal regulation of lncRNA expression in the lncRNA/PI3K/AKT axis is clearly associated with clinicopathological features and plays an important role in regulating biological functions. In the present review, the expression and biological functions of PI3K/AKT‑related lncRNAs both in vitro and in vivo over recent years, were comprehensively summarized and analyzed. Their correlation with clinicopathological features was also evaluated, with the objective of furnishing a solid theoretical foundation for clinical diagnosis and the monitoring of efficacy in digestive system neoplasms. The present review aimed to provide a comprehensive overview of the expression and biological functions of PI3K/AKT‑related lncRNAs in digestive system neoplasms and to assess their correlation with clinicopathological features. This endeavor seeks to establish a solid theoretical foundation for the clinical diagnosis and efficacy monitoring of digestive system tumors.

Keywords: AKT; PI3K; biomarker; digestive system neoplasms; long non‑coding RNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
A schematic representation of the PI3K/Akt pathway. The figure was created using Adobe Illustrator 2024 (v28.0; Adobe Inc.). RTK, receptor tyrosine kinase; GPCR, G protein-coupled receptor; PIP2, phosphatidylinositol 4,5-biphosphate; PIP3, phosphatidylinositol (3,4,5)-triphosphate; PDK1, phosphoinositide-dependent kinase-1.
Figure 2
Figure 2
lncRNAs associated with PI3K/AKT in digestive system neoplasms. The figure was created using Adobe Illustrator 2024 (v28.0; Adobe Inc.). LINC, long intergenic non-coding; lncRNA, long non-coding RNA.
Figure 3
Figure 3
Specific mechanisms of digestive system tumor progression between long non-coding RNAs and the PI3K/AKT pathway. The figure was created using Adobe Illustrator 2024 (v28.0; Adobe Inc.). miR, microRNA; LINC, long intergenic non-coding.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Gapstur SM, Drope JM, Jacobs EJ, Teras LR, McCullough ML, Douglas CE, Patel AV, Wender RC, Brawley OW. A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors. CA Cancer J Clin. 2018;68:446–470. doi: 10.3322/caac.21496. - DOI - PubMed
    1. Argueta EA, Moss SF. The prevention of gastric cancer by Helicobacter pylori eradication. Curr Opin Gastroenterol. 2021;37:625–630. doi: 10.1097/MOG.0000000000000777. - DOI - PubMed
    1. Gao S, Tan H, Li D. Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis. J Cell Mol Med. 2023;27:2661–2674. doi: 10.1111/jcmm.17841. - DOI - PMC - PubMed
    1. Gao S, Gang J, Yu M, Xin G, Tan H. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Cancer. 2021;21:791. doi: 10.1186/s12885-021-08520-1. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources